Physician profile
Mark E Feldman
NPI 1295818201
$4,509.77
in general payments reported to CMS, 2019-2025
10 companies · $2,222 in 2025
The $2,222 reported for 2025 was more than what 85% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $100 · 2021: $339 · 2022: $422 · 2023: $714 · 2024: $478 · 2025: $2,222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723 · Long Term Medical Supply Or Device Loan: $1,553 · Travel and Lodging: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,722.62 |
| Long Term Medical Supply Or Device Loan | $1,552.50 |
| Travel and Lodging | $139.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,235.69 | 2020-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $725.41 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $496.18 | 2023-2025 | |
| Depuy Synthes Sales INC. | $243.91 | 2022-2025 | Trumatch, Xcm Biologic Tissue Matrix, Matrixmandible |
| Checkpoint Surgical, INC | $231.87 | 2021-2022 | |
| Davol INC. | $149.35 | 2023 | Phasix Mesh |
| Polynovo North America LLC | $139.74 | 2025 | Novosorb Btm |
| Acell, INC. | $103.16 | 2019 | |
| Stryker Corporation | $101.89 | 2023 | Spy-Phi System |
| Medtronic, INC. | $82.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.